Salemonline Journal

Active Psoriatic Arthritis Market Study Report Based on Size, Shares, Opportunities, Industry Trends and Forecast to 2027

 Breaking News
  • No posts were found

Active Psoriatic Arthritis Market Study Report Based on Size, Shares, Opportunities, Industry Trends and Forecast to 2027

April 07
01:36 2021
Technological progressions in Active Psoriatic Arthritis therapeutics and management, significant prevalence of target disease across the globe, rising awareness towards the availability of biosimilar products for psoriatic arthritis, are among key factors expected to fuel the market growth

According to the current analysis of Emergen Research, the global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%. Significant growth in incidences of active psoriatic arthritis is observed across emerging countries together with increasing elderly population. Also, poor standard of living due to stressful work-life balance resulting in the overstimulation of immune system. Rising advancements in biosimilars and robust pipeline of biologic products are expressively enhancing the availability of safe and efficient psoriatic arthritis treatment. 

Request a sample copy of the report @ https://www.emergenresearch.com/request-sample/72

Key Highlights from the Report

  • Due to high emergence and employability of biologics and biosimilar products in potential treatment, biologics drug class segment accounted for the largest market share of approximately 39.8%. Moreover, traditional biologics have a capacity to improve complete immune system
  • Biologics and biosimilar products are mostly sold only on the basis of prescription. Prescription products segment in the products outlook accounted for the largest market revenue with a market share of approximately 47.5% in 2019
  • Existing market players operating in the industry have undertaken a number of strategies to propel in the market. Thus, in August 2019, Amgen and Bristol-Myers Squibb (BMS) announced to have acquired worldwide rights to Otezla (only oral non-biologic treatment for psoriasis and psoriatic arthritis) from Bristol-Myers Squibb’s merger partner Celgene
  • Key market players profiled for this industry analysis include Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies

Emergen research have segmented Active Psoriatic Arthritis Market on the basis of product, drug class, route of administration and region:

Product Outlook (Revenue in Million USD; 2017–2027)

  • Prescriptions
  • OTC
  • Other

Drug Class Outlook (Revenue in Million USD; 2017–2027)

  • Biologics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Other

By Route of Administration (Revenue in Million USD; 2017–2027)

  • Injectable
  • Oral
  • Topical

Regional Bifurcation:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/72

Focal Points of the Global Active Psoriatic Arthritis Market Report:

  • Market Coverage: This section of the report covers significant details on the key manufacturers, vital market segments, product innovation scope, and the forecast years. Additionally, it describes in detail the range of the product and the global Active Psoriatic Arthritismarket segmentation based on product type and application spectrum.
  • Executive Summary: In this chapter, the global market growth rate, competitive landscape, drivers and constraints, trends, limitations, and the key market segments have been discussed at length.
  • Regional Analysis: The report offers meaningful insights into the import and export trends, production and consumption capacities, estimated revenue share, and key players of each region dominating the market
  • Competitive Landscape:The report also discusses the course of development of each market player in this industry vertical during the forecast period. It further details on the firms, industries, organizations, vendors, and local manufacturers engaged in this industry. The leading products and services to gain global and regional market shares form the competitive landscape of the Active Psoriatic Arthritis industry.
  • Manufacturers’ portfolios: This section includes detailed information regarding the product portfolio of each local and global manufacturer, their strengths and weaknesses, product profiles, production value and capacity, and other vital information.

Table of Content

Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Active Psoriatic Arthritis Market Segmentation & Impact Analysis
    4.1. Active Psoriatic Arthritis Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Intensifying Prevalence of psoriatic arthritis
                    4.2.2.2. Emergence of potential medication
                    4.2.2.3. Healthcare reimbursements scenario
                    4.2.2.4. Availability of research finds from public and private bodies
          4.2.3. Market restraints analysis
                    4.2.3.1. High cost of treatment
                    4.2.3.2. Side effects associated with the treatment/surgery
    4.3. Technological Insights
    4.4. Clinical Pipeline Analysis
    4.5. Regulatory Framework
    4.6. Porter’s Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
    4.9. Covid-19 Impact Analysis

Chapter 5. Active Psoriatic Arthritis Market By Product Type Insights & Trends, Revenue (USD Million)
    5.1. Product Type Dynamics & Market Share, 2019 & 2027
          5.1.1. Prescriptions Products
          5.1.2. Over-the-Counter (OTC)
          5.1.3. Other

Chapter 6. Active Psoriatic Arthritis Market By Drug Class Insights & Trends Revenue (USD Million)
    6.1. Drug Class Dynamics & Market Share, 2019 & 2027
          6.1.1. Biologics
          6.1.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
          6.1.3. Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
          6.1.4. Other

CONTINUED…!!

Gain access to the full report by clicking here on the link @ https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market

Thank you for reading our report. To know more about the report, please connect with us, and our team will ensure the report is customized to meet your requirements.

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market

Related Articles

Recent Posts

Kuntai Machinery Launches A Wide Range of Cutting Machines To Offer Precision And Quality Production For Various Industries

Read Full Article